Tsuruo T - Search Results

1

Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer.

Hasumi Y, Mizukami H, Urabe M, Kohno T, Takeuchi K, Kume A, Momoeda M, Yoshikawa H, Tsuruo T, Shibuya M, Taketani Y, Ozawa K. Hasumi Y, et al. Among authors: tsuruo t. Cancer Res. 2002 Apr 1;62(7):2019-23. Cancer Res. 2002. PMID: 11929819

2

Overexpression of thioredoxin does not confer resistance to cisplatin in transfected human ovarian and colon cancer cell lines.

Yamada M, Tomida A, Yoshikawa H, Taketani Y, Tsuruo T. Yamada M, et al. Among authors: tsuruo t. Cancer Chemother Pharmacol. 1997;40(1):31-7. doi: 10.1007/s002800050621. Cancer Chemother Pharmacol. 1997. PMID: 9137526

3

Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.

Yamada M, Tomida A, Yoshikawa H, Taketani Y, Tsuruo T. Yamada M, et al. Among authors: tsuruo t. Clin Cancer Res. 1996 Feb;2(2):427-32. Clin Cancer Res. 1996. PMID: 9816187

4

Cellular sensitization to cisplatin and carboplatin with decreased removal of platinum-DNA adduct by glucose-regulated stress.

Yamada M, Tomida A, Yun J, Cai B, Yoshikawa H, Taketani Y, Tsuruo T. Yamada M, et al. Among authors: tsuruo t. Cancer Chemother Pharmacol. 1999;44(1):59-64. doi: 10.1007/s002800050945. Cancer Chemother Pharmacol. 1999. PMID: 10367750

5

Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.

Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, Ijichi H, Tanaka Y, Washida M, Morikane K, Fukushima Y, Yamori T, Tsuruo T, Kawabe T, Miyagishi M, Taira K, Sata M, Omata M. Guleng B, et al. Among authors: tsuruo t. Cancer Res. 2005 Jul 1;65(13):5864-71. doi: 10.1158/0008-5472.CAN-04-3833. Cancer Res. 2005. PMID: 15994964

6

SUMO-1 conjugation to intact DNA topoisomerase I amplifies cleavable complex formation induced by camptothecin.

Horie K, Tomida A, Sugimoto Y, Yasugi T, Yoshikawa H, Taketani Y, Tsuruo T. Horie K, et al. Among authors: tsuruo t. Oncogene. 2002 Nov 14;21(52):7913-22. doi: 10.1038/sj.onc.1205917. Oncogene. 2002. PMID: 12439742

7

Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo.

Tokuda E, Fujita N, Oh-hara T, Sato S, Kurata A, Katayama R, Itoh T, Takenawa T, Miyazono K, Tsuruo T. Tokuda E, et al. Among authors: tsuruo t. Cancer Res. 2007 Oct 15;67(20):9666-76. doi: 10.1158/0008-5472.CAN-07-1050. Cancer Res. 2007. PMID: 17942896

8

Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.

Yang L, Mashima T, Sato S, Mochizuki M, Sakamoto H, Yamori T, Oh-Hara T, Tsuruo T. Yang L, et al. Among authors: tsuruo t. Cancer Res. 2003 Feb 15;63(4):831-7. Cancer Res. 2003. PMID: 12591734

9

Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo.

Naasani I, Oh-Hashi F, Oh-Hara T, Feng WY, Johnston J, Chan K, Tsuruo T. Naasani I, et al. Among authors: tsuruo t. Cancer Res. 2003 Feb 15;63(4):824-30. Cancer Res. 2003. PMID: 12591733

10

Involvement of CD45 in adhesion and suppression of apoptosis of mouse malignant T-lymphoma cells.

Hanaoka K, Fujita N, Lee SH, Seimiya H, Naito M, Tsuruo T. Hanaoka K, et al. Among authors: tsuruo t. Cancer Res. 1995 May 15;55(10):2186-90. Cancer Res. 1995. PMID: 7743522

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

713 results

Search Page

Filters